Skip to main content

Innovative Footwear Clinically Proven to Reduce Knee Pain and Improve Joint Function

26 November 2024

Over 20 million people in the UK, have a Musculoskeletal (MSK) condition such as knee or back pain.

People are living longer with complex MSK conditions, increasing demand on MSK services.

MSK conditions are more common in areas of poverty and may affect some ethnic groups more than others, how patients access and experience care can also vary.

A standard treatment pathway for managing patients with knee osteoarthritis (OA) includes physiotherapy, weight loss, pain relief and walking aids.

Once patients experience joint symptoms (pain, stiffness) that have an impact on their quality of life or standard care treatment is no longer working, they should be considered for surgery.

AposHealth® Solution Intervention

Apos® is targeted for patients who would normally be referred for surgery and works on biomechanical and neuromuscular levels.

This is an innovative, non-invasive shoe that is personalised to treat the cause of a patient’s pain, by retraining how they walk to support better movement.

This National Institute for Health and Care Excellence (NICE) recommended device is clinically proven to relieve pain and improve function in the knees and lower back.

The image below shows how Apos® can be used with patients before surgery.

Two customised pods are attached to a tailored shoe device, which patients are required to wear for an hour a day, the pods are individually designed to meet a patient needs.

Neuromuscular retraining

The pods’ convexity creates micro-instability that increases proprioception and retrains the muscular system.

Biomechanical redistribution

Customised pod positioning reduces the forces acting on the  patient’s painful knee, reducing pain and improving their gait.

Enquire Now About Apos®

Complete our two minute enquiry form and your regional Clinical Nurse Advisor will respond with further details.

AposHealth Shoes - Walking Image
Innovative Orthopaedic Footwear

Proposed Pathway Diagram

See our Downloads ▼ section to view a printable PDF version.

Knee OAStandard care is no longer effectivePatient meets criteria for APOSPatient does not meet criteria for APOS.Suitable for surgery?Patient meets the crieriafor surgery, but choosesto use APOSKnee replacement carried outCore TherapiesSupportive TherapiesExerciseCommunity MSK ServicesSTANDARD CAREFUTURE CAREYESDISCHARGEDNORefer back to standard careValue Based Procurement6 Year evidence of delayed surgeryWeightManagementInformationand SupportManual TherapyWalking Aids*PharmacologicalManagement

MedTech Funding Mandate

From April 2024 Apos® will be covered by NHS England’s MedTech Funding Mandate policy (MTFM). The MTFM aims to ensure patients and the NHS benefit from clinically effective and cost saving medical technologies faster and fairly.

Technologies covered by the MTFM are typically funded by commissioners from their existing allocations. This is deliverable as the technologies supported are NICE recommended and meet the criteria to save costs and resources and make a return on investment within three years.

NHS Supply Chain work alongside the Health Innovation Network (HINs) and APOSHealth® to clinically implement this product. To find out more information, please contact our Care Pathway Team through the enquiry form.

Download our publications ▼

  • Proposed Pathway Illustration

    A detailed printable PDF version of the flow chart comparing standard care with future care.